Galanin Receptor Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Galanin receptor neurons express one or more of the three galanin receptor subtypes (GALR1, GALR2, GALR3), G protein-coupled receptors that bind the neuropeptide galanin. These neurons are widely distributed throughout the central and peripheral nervous systems and play diverse roles in modulating neurotransmission, neuroprotection, metabolism, and behavior.
| Property | Value |
|----------|-------|
| Category | Neuropeptide receptor neurons |
| Gene | GALR1, GALR2, GALR3 |
| Receptor Type | G protein-coupled receptor (GPCR) |
| Neurotransmitter | Galanin (30 amino acid neuropeptide) |
| Primary Brain Regions | Hypothalamus, hippocampus, amygdala, cortex, brainstem |
| Peripheral Sites | Gut, pancreas, adrenal gland |
| Taxonomy |
ID |
Name / Label |
| Cell Ontology (CL) |
CL:0000197 |
sensory receptor cell |
Galanin is a 30-amino acid neuropeptide:
- Discovery: First isolated in 1978 from porcine intestine
- Distribution: Widely expressed in CNS and PNS
- Processing: Derived from preprogalanin precursor
- Receptors: Binds to three receptor subtypes
Three galanin receptor genes exist:
GALR1 (GALR1):
- Chromosome 18q23
- Predominantly expressed in brain
- Coupled to Gi/o proteins
- Inhibits adenylate cyclase
GALR2 (GALR2):
- Chromosome 17q25.3
- Wide distribution
- Multiple signaling pathways
- Gi/o and Gq coupling
GALR3 (GALR3):
- Chromosome 22q13.1
- Lower expression levels
- Gi/o coupling
- Less studied
All galanin receptors are Class A GPCRs:
- Seven transmembrane domains
- N-terminal glycosylation
- Conserved DRY motif
- Multiple splice variants
¶ Anatomy and Distribution
Hypothalamus:
- Paraventricular nucleus (PVN)
- Arcuate nucleus (ARC)
- Supraoptic nucleus (SON)
- Lateral hypothalamus
Hippocampus:
- CA1-CA3 pyramidal layers
- Dentate gyrus granule cell layer
- Hilus/interneuron populations
Amygdala:
- Central nucleus
- Basolateral complex
- Cortical nuclei
Cerebral Cortex:
- Layer V pyramidal neurons
- Various interneuron subtypes
Brainstem:
- Dorsal raphe nucleus
- Locus coeruleus
- Nucleus of the solitary tract
- Periaqueductal gray
Spinal Cord:
- Dorsal horn (laminae I-II)
- Motor neurons (ventral horn)
- Enteric nervous system: Gut motility
- Pancreas: Insulin secretion
- Adrenal gland: Stress response
- Cardiovascular system: Blood flow
Galanin receptor activation triggers:
GALR1/GALR3 (Gi/o-coupled):
- Inhibition of adenylate cyclase
- Activation of inward-rectifier K+ channels
- Inhibition of voltage-gated Ca2+ channels
- MAPK activation
GALR2 (Gq/Gi-coupled):
- Phospholipase C activation
- IP3/DAG production
- Calcium release
- Multiple downstream effects
Galanin acts as a neuromodulator:
-
Inhibits neurotransmitter release
-
Postsynaptic effects
- Hyperpolarizes neurons
- Reduces firing rates
- Alters plasticity
-
Presynaptic modulation
- Reduces neurotransmitter release
- Acts as autoreceptor
- Heterosynaptic effects
Pain Modulation:
- Analgesic effects in spinal cord
- Modulates nociceptive transmission
- Involved in chronic pain states
Feeding and Metabolism:
- Inhibits food intake (hypothalamus)
- Reduces appetite
- Modulates energy balance
Neuroprotection:
- Promotes neuronal survival
- Reduces excitotoxicity
- Supports regeneration
Learning and Memory:
- Hippocampal memory processes
- Synaptic plasticity modulation
- Cognitive effects
Mood and Behavior:
- Anxiety-related behaviors
- Depression-like states
- Social interaction
Galanin system develops early:
- Embryonic: Expression in developing brain
- Perinatal: Significant increases
- Postnatal: Refinement of patterns
- Adult: Stable distribution
- Neuronal differentiation
- Axon pathfinding
- Synapse formation
- Circuit maturation
Galanin in AD:
- Galanin hyperinnervation: compensatory mechanism
- GALR2 upregulation: in hippocampus
- Cognitive effects: galanin impairs memory
- Neuroprotection: trophic support
- Therapeutic targeting: galanin antagonists
Research:
- Galanin increases in AD brain
- Modulates cholinergic neurons
- May accelerate cognitive decline
In PD:
- Nigrostriatal galanin: Altered expression
- Motor effects: Modulates basal ganglia
- Neuroprotection: Supports dopaminergic neurons
- L-DOPA dyskinesias: Role in dyskinesia development
- Therapeutic potential: galanin analogs
Galanin is anticonvulsant:
- Reduces seizure severity
- Modulates excitability
- Protects against excitotoxicity
- Therapeutic application: galanin agonists
In pain pathways:
- Analgesic effects: Spinal and supraspinal
- Inflammatory pain: Modulates responses
- Neuropathic pain: Altered expression
- Potential therapy: galanin agonists
¶ Depression and Anxiety
- Antidepressant-like effects: galanin in mood
- Anxiety modulation: regional effects
- Stress response: HPA axis involvement
- Therapeutic potential
- Feeding behavior: appetite suppression
- Energy expenditure: metabolic effects
- Diabetes: pancreatic galanin
- Obesity: potential target
Galanin receptor targeting:
Agonists:
- Galanin peptide analogs
- Small molecule agonists
- Selective for receptor subtypes
Antagonists:
- GALR1-selective antagonists
- GALR2-selective antagonists
- Pan-receptor antagonists
- Pain management: Galanin agonists for chronic pain
- Epilepsy: Anticonvulsant potential
- Metabolic disorders: Feeding regulation
- Mood disorders: Antidepressant effects
- Neuroprotection: Neurodegenerative diseases
- Sedation: CNS depression
- Weight loss: Appetite suppression
- Seizures: At high doses
- GI effects: Motility changes
- Receptor binding assays
- mRNA localization (in situ hybridization)
- Immunohistochemistry
- Electrophysiology
- Behavioral assays
- GALR1 knockout mice
- GALR2 knockout mice
- GALR3 knockout mice
- Transgenic models
- Viral manipulations
](/cell-types/hypothalamic-neurons)## Background
The study of Galanin Receptor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.